Specification
INDICA
THC: 27-32%
Balancing Focus & Stress Relief
Product details
A Legendary Lineage of Potency and Elegance
Targaryen Pink is a 7g small-lot strain that embodies the spirit of Kushkraft’s legacy. With a THC range of 27-32%, this majestic strain offers a powerful cerebral lift followed by soothing body relaxation, making it perfect for those seeking a bold yet balanced cannabis experience. Whether conquering creative challenges or easing stress, Targaryen Pink reigns supreme.
Bold Flavours, Majestic Effects
Flavour Profile & Effects
- Flavour Profile: A fiery blend of earthy spice, zesty citrus, and subtle floral undertones that captivates the senses.
- Effects: A dynamic combination of uplifting mental clarity and calming body relaxation, ideal for balancing focus and stress relief.
A Powerful and Unique Terpene Profile
Dominant Terpenes
- Caryophyllene: Spicy and bold, known for its anti-inflammatory properties.
- Limonene: Bright citrus notes that uplift mood and enhance focus.
- Myrcene: Earthy and calming, promotes relaxation and ease.
Usage Recommendation:
Day or Evening – Designed for creative pursuits, daytime adventures, or unwinding in style.
A Strain Fit for Royalty
For cannabis enthusiasts who demand bold flavors, unparalleled effects, and a premium smoking experience, Targaryen Pink offers:
- Regal Potency: THC levels of 27-32%, ideal for seasoned users.
- Dynamic Effects: Uplifting euphoria paired with soothing calm.
- Distinct Flavor: A rich blend of spice, citrus, and floral tones.
- Exclusive Craftsmanship: Small-lot production for unmatched quality.
You must be logged in to post a review.
Targaryen Pink, Game of Pinks 7g
Born of Fire, Crafted for Excellence
A Majestic Strain That Commands Attention and Delivers Excellence.
| Strain Type | Premium Indica |
|---|---|
| THC Range | 27-32% |
| Terpenes | Caryophyllene, Limonene, Myrcene |
| Product Weight | 7g |
| Packaging | Sealed for freshness and exclusivity, includes a packaged Integra boost pack |








Reviews
There are no reviews yet.